<DOC>
	<DOC>NCT01397903</DOC>
	<brief_summary>The purpose is to assess the response of add-on therapy, based on CGI-I scale, at 4 weeks, in patients with MDD who had an inadequate disease control with antidepressant medication.</brief_summary>
	<brief_title>Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response</brief_title>
	<detailed_description>A cross-sectional observational study to describe treatment management of patients with Major Depressive Disorder (MDD) and inadequate response to antidepressants in Greece</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Diagnosis of MDD as per DSMIV Patients with an inadequate disease control during antidepressant therapy Patients who already receive addon therapy and have completed 45 weeks of treatment at the time of their enrolment in the study. Patients fulfilling criteria for diagnosis of any other psychiatric condition (except for MDD), as per DSMIV Axis I, Concomitant organic mental disorder or mental retardation Substance abuse or dependence (with the exception of nicotine dependence), as defined by DSMIV criteria Participation in another study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>antidepressant therapy, inadequate control, add-on therapy</keyword>
</DOC>